---
title: Corval Insights (2)
description: Corval Insights (2)
---

[Skip to content](https://insights.corval.io/page/2#main-content)

[![Corval-logo-color](https://insights.corval.io/hs-fs/hubfs/MKT%20-%20Social%20Suggested%20Images/Corval-logo-color.png?width=200&height=105&name=Corval-logo-color.png) ](https://corval.io/)

- [The Solution](https://corval.io/biopharma-commercialization-solution/)
  
  Show submenu for The Solution 
  
    - [Early Biopharma](https://corval.io/early-biopharma/)
    - [Mid-Stage Biopharma](https://corval.io/mid-stage-biopharma/)
    - [Service Providers](https://corval.io/service-providers/)
- [How It Works](https://corval.io/how-it-works/)
- [Request a Demo](https://corval.io/request-a-demo/)
- [About Us](https://corval.io/about/)
- [Insights](https://insights.corval.io)

Open main navigation

Close main navigation

- [The Solution](https://corval.io/biopharma-commercialization-solution/)
  
  Show submenu for The Solution 
  
    - [Early Biopharma](https://corval.io/early-biopharma/)
    - [Mid-Stage Biopharma](https://corval.io/mid-stage-biopharma/)
    - [Service Providers](https://corval.io/service-providers/)
- [How It Works](https://corval.io/how-it-works/)
- [Request a Demo](https://corval.io/request-a-demo/)
- [About Us](https://corval.io/about/)
- [Insights](https://insights.corval.io)

# Clarity

Welcome to Clarity! Corval’s insights, perspective, and vision regarding the best practices of biopharma commercialization.

[![](https://insights.corval.io/hubfs/Venn%20blog%20featured%203.png) ](https://insights.corval.io/owning-the-overlap-where-strategy-tech-and-expertise-converge)

## [Owning the Overlap: Where Strategy, Tech, and Expertise Converge](https://insights.corval.io/owning-the-overlap-where-strategy-tech-and-expertise-converge)

[Read more](https://insights.corval.io/owning-the-overlap-where-strategy-tech-and-expertise-converge)

[![](https://insights.corval.io/hubfs/founderletter2025B.jpg) ](https://insights.corval.io/navigating-change-embracing-opportunity-a-letter-from-corvals-founder)

## [Navigating Change, Embracing Opportunity—A Letter from Corval’s Founder](https://insights.corval.io/navigating-change-embracing-opportunity-a-letter-from-corvals-founder)

[Read more](https://insights.corval.io/navigating-change-embracing-opportunity-a-letter-from-corvals-founder)

[![illustration of Corval customers jumping over milestones](https://insights.corval.io/hubfs/Blog-Milestones.jpg) ](https://insights.corval.io/biopharma-milestones-the-markers-of-our-industry)

## [Biopharma Milestones—the Markers of Our Industry](https://insights.corval.io/biopharma-milestones-the-markers-of-our-industry)

[Read more](https://insights.corval.io/biopharma-milestones-the-markers-of-our-industry)

[![](https://insights.corval.io/hubfs/San%20Fransisco_JPM.jpg) ](https://insights.corval.io/beyond-the-conference-what-going-to-jpm-has-meant-through-the-years)

## [Beyond the Conference—What “Going to JPM” Has Meant Through the Years](https://insights.corval.io/beyond-the-conference-what-going-to-jpm-has-meant-through-the-years)

[Read more](https://insights.corval.io/beyond-the-conference-what-going-to-jpm-has-meant-through-the-years)

[![](https://insights.corval.io/hubfs/full%20stack%20blog.jpg) ](https://insights.corval.io/video-agile-technology-full-stack-engineering-in-biopharma-commercialization)

## [VIDEO: Agile Technology & Full Stack Engineering in Biopharma Commercialization](https://insights.corval.io/video-agile-technology-full-stack-engineering-in-biopharma-commercialization)

[Read more](https://insights.corval.io/video-agile-technology-full-stack-engineering-in-biopharma-commercialization)

[![biopharma consulting firm](https://insights.corval.io/hubfs/Meeting%20Graphic_Planning.jpg) ](https://insights.corval.io/how-biopharma-consulting-firms-can-plan-and-adapt-to-dynamic-market-trends-and-regulations)

## [How Biopharma Consulting Firms Can Plan and Adapt to Dynamic Market Trends and Regulations](https://insights.corval.io/how-biopharma-consulting-firms-can-plan-and-adapt-to-dynamic-market-trends-and-regulations)

[Read more](https://insights.corval.io/how-biopharma-consulting-firms-can-plan-and-adapt-to-dynamic-market-trends-and-regulations)

[![Sue Nemetz and Kerrie Brady](https://insights.corval.io/hubfs/Sue%20Kerrie%20blog.png) ](https://insights.corval.io/commercialization-and-launch-what-keeps-a-biotech-ceo-up-at-night)

## [Podcast: Commercialization and Launch—What Keeps a Biotech CEO Up at Night?](https://insights.corval.io/commercialization-and-launch-what-keeps-a-biotech-ceo-up-at-night)

[Read more](https://insights.corval.io/commercialization-and-launch-what-keeps-a-biotech-ceo-up-at-night)

[![In this transformative time—at the intersection of technology and our industry—a curious, learning mindset is essential for success.](https://insights.corval.io/hubfs/driving%20biopharma%20blog.jpg) ](https://insights.corval.io/driving-biopharma-forward-the-role-of-technology-in-commercialization)

## [Driving Biopharma Forward—The Role of Technology in Commercialization](https://insights.corval.io/driving-biopharma-forward-the-role-of-technology-in-commercialization)

[Read more](https://insights.corval.io/driving-biopharma-forward-the-role-of-technology-in-commercialization)

[![](https://insights.corval.io/hubfs/Budget%20Alignment_2.jpg) ](https://insights.corval.io/navigating-pharma-budget-season-three-principles-to-align-strategy-and-financial-planning)

## [Navigating Pharma Budget Season: Three Principles to Align Strategy and Financial Planning](https://insights.corval.io/navigating-pharma-budget-season-three-principles-to-align-strategy-and-financial-planning)

[Read more](https://insights.corval.io/navigating-pharma-budget-season-three-principles-to-align-strategy-and-financial-planning)

[First ](https://insights.corval.io) [Prev ](https://insights.corval.io) [1](https://insights.corval.io) [2](https://insights.corval.io/page/2) [3](https://insights.corval.io/page/3) [4](https://insights.corval.io/page/4) [5](https://insights.corval.io/page/5) [Next ](https://insights.corval.io/page/3) [Last ](https://insights.corval.io/page/6)

- [Why Corval](https://corval.io/why-corval/)
- [How It Works](https://corval.io/how-it-works/)
- [About](https://corval.io/about/)
- [Learn More](https://corval.io/contact-us/)
- [Request a Demo](https://corval.io/request-a-demo/)

- [Clear Path to Market](https://corval.io/clear-path-to-market/)
- [A Better Approach](https://corval.io/a-better-approach/)
- [Features](https://corval.io/features/)
- [Case Studies](https://corval.io/case-studies/)

[linkedin-in icon ](https://www.linkedin.com/company/corvalllc/)

- [Privacy](https://corval.io/?page_id=3)
- [Terms and Conditions](https://corval.io/terms-and-conditions/)
- The Corval® trademark is owned by Corval LLC.
  
  Copyright © 2023 Corval LLC